Home
>
National Drug Code (NDC)
>
MiraLAX
MiraLAX - 55154-5035-6 - (Polyethylene Glycol 3350)
Drug Information of MiraLAX
| Product NDC: | 55154-5035 |
| Proprietary Name: | MiraLAX |
| Non Proprietary Name: | Polyethylene Glycol 3350 |
| Active Ingredient(s): | 17 g/17g & nbsp; Polyethylene Glycol 3350 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MiraLAX
| Product NDC: | 55154-5035 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA022015 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090223 |
Package Information of MiraLAX
| Package NDC: | 55154-5035-6 |
| Package Description: | 6 PACKET in 1 BAG (55154-5035-6) > 17 g in 1 PACKET |
NDC Information of MiraLAX
| NDC Code | 55154-5035-6 |
| Proprietary Name | MiraLAX |
| Package Description | 6 PACKET in 1 BAG (55154-5035-6) > 17 g in 1 PACKET |
| Product NDC | 55154-5035 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Polyethylene Glycol 3350 |
| Dosage Form Name | POWDER |
| Route Name | ORAL |
| Start Marketing Date | 20090223 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Strength Number | 17 |
| Strength Unit | g/17g |
| Pharmaceutical Classes |
